NuclearMedix
StartupBiotech & Life SciencesBritish
Imperial College London spinout developing scalable 18F radiotracer radiopharmaceuticals to address the supply gap of SSTR-PET tracers used in diagnosing and treating neuroendocrine tumours.
Locations
London, United Kingdom (Headquarters)
Gn1 Commonwealth Building, Hammersmith Hospital, London, Greater London, W12 0NN, United Kingdom
View on map